Abstract
Aim To study changes in markers for myocardial direct injury and dysfunction and endothelial dysfunction (ED) indexes in patients with indolent lymphoma during the antitumor treatment.Material and methods Current antitumor therapy for lymphoma is often associated with cardio- and vasculotoxicity, studying of which is a relevant scientific direction. Markers for myocardial direct injury and dysfunction and ED indexes were studied in patients with indolent lymphomas receiving polychemotherapy (PCT). The study included 77 patients with newly diagnosed indolent type lymphoma. The main group (n=52): mean age, 63.4±2.8 years, 15 (28.8 %) men who had received one course of PCT. The comparison group (n=25): mean age, 61.8±3.7 years, 8 (32 %) men who had not received PCT. Troponin I (TnI), high-sensitivity troponin I (hs-сTnI), heart-type fatty acid binding protein (h-FAВР), and N-terminal pro-B-type natriuretic peptide (NT-prоBNP) were measured in patients of both groups. ED was evaluated by measuring the level of vascular cell adhesion molecule (VCAM) and by assessing the structure and function condition of small blood vessels using photoplethysmography. In both groups, the study parameters were determined at the start of the study (T1) and following the PCT course in the main group; if the PCT schedule included anthracycline antibiotics, the second point (T2) was assessed at 6 h following the drug administration.Results In both groups, the level of NT-proBNP was increased. This increase was significantly more pronounced in the comparison group (49.896±23.228 vs 20.877±8.534 pmol/l, respectively, p=0.011) whereas a tendency to its increase was observed after the PCT course. Before the start of the treatment, laboratory and instrumental signs of ED were noticed: the level of VCAM was 4951±1297 and 3225±757 ng/ml in the comparison group and the main group, respectively (р=0.246); reflection index was <1.8 in 23 (44.2%) patients of the main group and in 16 (64%) patients of the comparison group (р=0.098). During the PTC course, the endothelial function significantly improved; the level of VCAM decreased by 748 ng/ml (p=0.016), which was associated with significant decreases in erythrocyte sedimentation rate by 2.71 mm/h (р=0.027) and lactate dehydrogenase level by 62.38 U/l (р=0.026). Statistically significant decreases in other inflammatory markers (alpha-2-globulin, fibrinogen, C-reactive protein, neutrophil count) were not observed.Conclusion The level of NT-proBNP showed the highest sensitivity in assessing the cardiotoxic effect of PCT. The dynamics of VCAM level suggested a possible role of the disease itself in the development of ED in this patient group.
Highlights
ФГАОУ ВО Первый Московский государственный медицинский университет им
Динамика исследуемых маркеров повреждения миокарда, NT-proBNP, острофазовых показателей в основной группе на фоне противоопухолевой терапии
Shah N, Cabanillas F, McIntyre B, Feng L, McLaughlin P, Rodriguez MA et al Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas
Summary
Изучить динамику маркеров прямого повреждения и дисфункции миокарда, а также показателей дисфункции эндотелия (ДЭ) у пациентов с индолентными лимфомами на фоне противоопухолевой терапии. Проведено исследование маркеров прямого повреждения и дисфункции миокарда, а также параметров ДЭ у пациентов с индолентными лимфомами на фоне полихимиотерапии (ПХТ). Оценка динамики маркеров прямого повреждения и дисфункции миокарда, показателей дисфункции эндотелия у пациентов с индолентными лимфомами на фоне противоопухолевой терапии. Поэтому нами было проведено исследова‐ ние динамики маркеров прямого повреждения миокарда и показателей ДЭ у пациентов с индолентными лимфома‐ ми на фоне ПХТ. У пациентов ос‐ новной группы определение функции эндотелия, уров‐ ня маркеров прямого повреждения миокарда и уровня N-концевого мозгового натрийуретического пропепти‐ да (NT-proBNP) проводили до (Т1) и после (Т3) одно‐ го курса ПХТ, что в среднем составило около 7 дней. Динамика исследуемых маркеров повреждения миокарда, NT-proBNP, острофазовых показателей в основной группе на фоне противоопухолевой терапии
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.